Country websites:

Regenerative Medicine: The road to healing

We want to be at the forefront when technologies of this kind make the breakthrough.

Dr. Olaf Schermeier
Member of the Management Board of Fresenius Medical Care, responsible for Research and Development

Strategic investment: A win-win situation

Blood vessels from the bioreactor

In the future, our blood vessels could potentially offer hemodialysis patients a safer and more durable vascular access.

Dr. Jeffrey Lawson
CEO Humacyte, Inc.

About Regenerative Medicine

Related Content